GoKawiilNIH moves to shift hundreds of millions in infectious-disease research to Pentagon
Two NIH employees say the agency has signed an agreement with the Department of Defense to transfer research projects, currently valued in the hundreds of millions of dollars, from its infectious-diseases institute to military biodefence programs. The NIH is reportedly still selecting which projects to hand over and hopes to finalize the deal before the fiscal year ends in September, when certain funds would otherwise expire. NIH officials describe the move as separating civilian public-health work from defense-related priorities, while a former top HHS lawyer questions whether simply redirecting funds between agencies in this way is legally permissible.
GoKawiil's interpretation of the reporting above, not reported fact.
The shift raises questions about oversight and transparency of biomedical research funding, since defense-run programs typically operate under different disclosure rules than civilian science agencies. Critics worry that folding infectious-disease work into military biodefence could blur the line between public-health research and weapons-adjacent programs, fueling public distrust. The legal ambiguity around transferring appropriated funds between agencies could also invite congressional or judicial scrutiny.
- NIH and DOD have reportedly signed an agreement to move infectious-disease research funding to military biodefence programs.
- The transfer, worth hundreds of millions of dollars, is meant to be finalized before the fiscal year ends in September.
- A former HHS chief lawyer questions whether such a fund transfer between agencies is legally sound.
Source: nature.com — Kozlov, 2026-09-04
Published there as: “Revealed: inside the US military's plan to tap huge sums from the NIH”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.